CentralBio Co.
Latest round
- Series B
Last raised
- Jul 2022
Total raised
- $9.6M
Investors
- 5
About CentralBio Co.
, Ltd. is a physical, chemical, and biological research and development institute that specializes in chemicals and crop protection agents. As of July 2022, the company had 120 employees. The company's services include non-clinical trials on behalf of the Ministry of Food and Drug Safety for Medicines/health functional foods/cosmetics; the Ministry of Environment for registration and evaluation of chemical substances; and Rural Development Administration for agrochemical raw materials and items consignment test section. CentralBio provides a total service for chemical hazard evaluation. In addition, Central Bio has established an analysis center to conduct tests such as polymer analysis required for the registration of chemical substances.5 billion., Ltd. in purchasing advanced equipment and expanding its animal testing facilities. Central Bio also plans an initial public offering (IPO) as it is aiming to enter the KOSDAQ market within the first half of 2024.
Who invested in CentralBio Co.
5 investors across 2 rounds
See all investors in CentralBio Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CentralBio Co.
Who invested in CentralBio Co.?
CentralBio Co. has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CentralBio Co. raised?
CentralBio Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CentralBio Co. last raise money?
CentralBio Co.'s most recent round on record is a Series B, in Jul 2022.
What does CentralBio Co. do?
CentralBio Co. is a pharmaceuticals company.
Where is CentralBio Co. headquartered?
CentralBio Co. is headquartered in Incheon, South Korea.
Which VCs invest in companies like CentralBio Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at CentralBio Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like CentralBio Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.